NO
Roles
Therapeutic Areas
Astellas Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Zolbetuximab | CLDN18.2-positive Gastric/GEJ Cancer | Regulatory Review |
| Enfortumab vedotin | Urothelial Carcinoma | Phase 3 |
| AT845 (FORCE) | Late-Onset Pompe Disease | Phase 1/2 |
| ASP2138 | Solid Tumors | Phase 1 |
| Gavocabtagene autoleucel | Autoimmune Diseases | Phase 1/2 |